Patient-reported symptom burden under chemotherapy with fluorouracil
Recruiting
- Conditions
- Colorectal cancer
- Registration Number
- DRKS00022869
- Lead Sponsor
- Pharmazeutisches Institut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Diagnosis of colorectal cancer; ongoing or new treatment with fluorouracil; age = 18 years; electronic consent from the patient; sufficient knowledge of the German language
Exclusion Criteria
Patients who are physically and mentally not capable of independently completing the electronic patient questionnaire (e.g. due to dementia, Alzheimer's disease)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptom burden using PRO-CTCAE via a mobile, browser-compatible application, once a week for twelve weeks
- Secondary Outcome Measures
Name Time Method